Back to Agenda
Part 1: Introduction - Industry Perspectives on HTA Regulation Implementation
Session Chair(s)
Ansgar Hebborn, PhD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
Speaker(s)
Ansgar Hebborn, PhD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
James Ryan, MSc
Director, Global HTA Policy , AstraZeneca (Global), UK, United Kingdom
Claudine Sapède, PharmD
Director, Global HTA Policy, NOVARTIS INTERNATIONAL, Switzerland
Inka Heikkinen, MBA, MSc
Regulatory Policy Lead, Lundbeck, Denmark
Have an account?